# GIMAP5

## Overview
GIMAP5, or GTPase of the immunity-associated protein family member 5, is a gene that encodes a small GTP-binding protein involved in immune system regulation. The protein, also referred to as GTPase, IMAP family member 5, is categorized as a GTPase and plays a pivotal role in the survival and homeostasis of lymphocytes, particularly T cells. It is primarily localized in the mitochondria, where it contributes to maintaining mitochondrial integrity and cellular energy balance. GIMAP5 is crucial for protecting cells from apoptosis, thereby supporting the proper development and function of T lymphocytes. The protein's interactions with Bcl-2 family proteins and its involvement in signaling pathways such as MAPK and NF-κB underscore its importance in regulating immune responses and preventing autoimmune conditions (Patterson2019Loss; Saunders2010Putative). Mutations in the GIMAP5 gene have been linked to various immune-related diseases, highlighting its significance in maintaining immune homeostasis (Heinonen2015GIMAP; Park2021Human).

## Structure
The GIMAP5 protein is a member of the GIMAP family, which consists of small GTP-binding proteins conserved among vertebrates. The human GIMAP5 protein is composed of 307 amino acids and features several structural domains. It contains a GIMAP GTPase domain at the N-terminus, which includes a guanine nucleotide-binding domain characterized by five G motifs (G1, G2, G3, G4, and G5) involved in nucleotide binding (Limoges2021The). This domain is functional and its activity may be regulated by homo- or hetero-dimerization, although GIMAP5 can bind GTP with high affinity but cannot hydrolyze it independently (Limoges2021The).

The protein also includes a helical segment that folds back onto the GTPase domain, potentially mediating interactions with partner proteins (Limoges2021The). At the C-terminus, GIMAP5 has a transmembrane hydrophobic domain, which is involved in membrane anchoring and targeting the protein to intracellular organelles (Limoges2021The). In rats, GIMAP5 exists in two isoforms, GIMAP5v1 and GIMAP5v2, both retaining the coiled-coil regions and the transmembrane domain (Limoges2021The). The structural domains suggest a complex tertiary structure with potential quaternary interactions through dimerization (Limoges2021The).

## Function
GIMAP5 is a member of the GTPase of the immunity-associated protein family, playing a crucial role in the survival and homeostasis of lymphocytes, particularly T cells. It is primarily active in the mitochondria, where it helps maintain mitochondrial integrity and cellular energy balance. GIMAP5 is involved in protecting cells from apoptosis, which is essential for the proper development and function of T lymphocytes (Saunders2010Putative).

In healthy human cells, GIMAP5 contributes to the regulation of T-cell survival by influencing mitochondrial permeability and interacting with Bcl-2 family proteins, which are known to regulate apoptosis. It also participates in signaling pathways such as MAPK and NF-κB, which are crucial for cell survival and immune responses (Saunders2010Putative). GIMAP5's role in maintaining immune homeostasis is further supported by its involvement in regulating calcium signaling and endoplasmic reticulum stress pathways, which are important for T-cell function and survival (Saunders2010Putative).

The protein's activity is essential for preventing excessive inflammatory responses and maintaining a balanced T-cell polarization, thereby contributing to immune system stability and preventing the development of autoimmune conditions (Patterson2019Loss).

## Clinical Significance
Mutations and altered expression of the GIMAP5 gene have been implicated in several immune-related diseases. In humans, loss-of-function mutations in GIMAP5 are associated with a novel immunodeficiency disease characterized by severe progressive lymphopenia, autoimmunity, and liver disease. This condition results from recessive mutations leading to a loss of naïve T lymphocytes and an increase in senescent T cells, contributing to profound immunodeficiency (Park2021Human). 

GIMAP5 mutations are also linked to type 1 diabetes (T1D), asthma, and allergic sensitization. The SNP rs6965571 in GIMAP5 is associated with T1D in specific Finnish populations, although its significance diminishes after correcting for multiple testing. This SNP is also a risk factor for asthma and allergic sensitization, with the allele A being particularly implicated (Heinonen2015GIMAP). 

In animal models, GIMAP5 deficiency leads to severe immune dysregulation, including lymphopenia, intestinal inflammation, and liver abnormalities. Gimap5-deficient mice exhibit impaired lymphocyte proliferation and survival, contributing to conditions like colitis and wasting disease (Barnes2010Loss). These findings underscore the critical role of GIMAP5 in maintaining immune homeostasis and its potential impact on disease susceptibility.

## Interactions
GIMAP5 is known to interact with several proteins, influencing various cellular processes. In T lymphocytes, GIMAP5 is localized on lysosomes and certain vesicles, where it colocalizes with lysosomal membrane proteins such as LAMP2 and TPC2, but not with the lysosomal lumen marker Lysotracker Red. It also colocalizes with Rabs 4, 5, 7, 9, and 11, which are markers of early and late endocytic and recycling compartments (Serrano2017GTPase). GIMAP5 interacts with microtubules, particularly the GIMAP5v2 isoform, which shows a higher colocalization coefficient with microtubules. This interaction suggests a role in organelle movement, as GIMAP5v2-containing vesicles move along microtubules and significantly colocalize with the molecular motor protein kinesin, but not with dynein (Serrano2017GTPase).

In the context of lung cancer, GIMAP5 interacts with the mannose-6-phosphate receptor (M6PR). This interaction is significant in inhibiting lung cancer growth by promoting the transport of M6PR from the cytoplasm to the cell membrane, thereby affecting the epithelial-mesenchymal transition (EMT) process (Dai2021Gimap5). The interaction between GIMAP5 and M6PR was confirmed through co-immunoprecipitation and molecular docking studies (Dai2021Gimap5).


## References


[1. (Dai2021Gimap5) Pei Dai, Zhongxiang Tang, Pinglang Ruan, Ousman Bajinka, Dan Liu, and Yurong Tan. Gimap5 inhibits lung cancer growth by interacting with m6pr. Frontiers in Oncology, September 2021. URL: http://dx.doi.org/10.3389/fonc.2021.699847, doi:10.3389/fonc.2021.699847. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2021.699847)

[2. (Heinonen2015GIMAP) Mirkka T. Heinonen, Antti-Pekka Laine, Cilla Söderhäll, Olena Gruzieva, Sini Rautio, Erik Melén, Göran Pershagen, Harri J. Lähdesmäki, Mikael Knip, Jorma Ilonen, Tiina A. Henttinen, Juha Kere, Riitta Lahesmaa, Mikael Knip, Per-Henrik Groop, Jorma Ilonen, Anneli Lappi, Timo Otonkoski, Marja-Terrtu Saha, Olli Simell, Timo Talvitie, Outi Vaarala, Riitta Veijola, Henrikka Aito, Jonas Bondestam, Thomas Dahllund, Johanna Granvik, Maarit Haapalehto-Ikonen, Anu-Maaria Hämäläinen, Hanna Huopio, Christian Johansson, Anne Kinnala, Jussi Korhonen, Paavo Korpela, Maarit Korteniemi, Pentti Lautala, Kaija Lindström, Päivi Miettinen, Taina Mustila, Anja Nuuja, Päivi Nykänen, Jussi Ojanperä, Anne Putto-Laurila, Marja-Terttu Saha, Juhani Sankila, Anne-Maarit Suomi, Sirpa Tenhola, Pentti Varimo, Riitta Veijola, Ritva Virransalo, Pentti Vuolukka, and Samuli Ylitalo. Gimap gtpase family genes: potential modifiers in autoimmune diabetes, asthma, and allergy. The Journal of Immunology, 194(12):5885–5894, June 2015. URL: http://dx.doi.org/10.4049/jimmunol.1500016, doi:10.4049/jimmunol.1500016. This article has 28 citations.](https://doi.org/10.4049/jimmunol.1500016)

[3. (Serrano2017GTPase) Daniel Serrano, Farnaz Ghobadi, Guylain Boulay, Subburaj Ilangumaran, Christine Lavoie, and Sheela Ramanathan. Gtpase of the immune-associated nucleotide protein 5 regulates the lysosomal calcium compartment in t lymphocytes. Frontiers in Immunology, February 2017. URL: http://dx.doi.org/10.3389/fimmu.2017.00094, doi:10.3389/fimmu.2017.00094. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2017.00094)

[4. (Limoges2021The) Marc-André Limoges, Maryse Cloutier, Madhuparna Nandi, Subburaj Ilangumaran, and Sheela Ramanathan. The gimap family proteins: an incomplete puzzle. Frontiers in Immunology, May 2021. URL: http://dx.doi.org/10.3389/fimmu.2021.679739, doi:10.3389/fimmu.2021.679739. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2021.679739)

[5. (Saunders2010Putative) Amy Saunders, Louise M. C. Webb, Michelle L. Janas, Amanda Hutchings, John Pascall, Christine Carter, Nicholas Pugh, Geoff Morgan, Martin Turner, and Geoffrey W. Butcher. Putative gtpase gimap1 is critical for the development of mature b and t lymphocytes. Blood, 115(16):3249–3257, April 2010. URL: http://dx.doi.org/10.1182/blood-2009-08-237586, doi:10.1182/blood-2009-08-237586. This article has 47 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2009-08-237586)

6. (Park2021Human) Human immunodeficiency reveals GIMAP5 as lymphocyte-specific regulator of senescence. This article has 3 citations.

[7. (Patterson2019Loss) Andrew R. Patterson, Paige Bolcas, Kristin Lampe, Rachel Cantrell, Brandy Ruff, Ian Lewkowich, Simon P. Hogan, Edith M. Janssen, Jack Bleesing, Gurjit K. Khurana Hershey, and Kasper Hoebe. Loss of gtpase of immunity-associated protein 5 (gimap5) promotes pathogenic cd4+ t-cell development and allergic airway disease. Journal of Allergy and Clinical Immunology, 143(1):245-257.e6, January 2019. URL: http://dx.doi.org/10.1016/j.jaci.2018.10.018, doi:10.1016/j.jaci.2018.10.018. This article has 9 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.jaci.2018.10.018)

[8. (Barnes2010Loss) Michael J. Barnes, Halil Aksoylar, Philippe Krebs, Tristan Bourdeau, Carrie N. Arnold, Yu Xia, Kevin Khovananth, Isaac Engel, Sosathya Sovath, Kristin Lampe, Eleana Laws, Amy Saunders, Geoffrey W. Butcher, Mitchell Kronenberg, Kris Steinbrecher, David Hildeman, H. Leighton Grimes, Bruce Beutler, and Kasper Hoebe. Loss of t cell and b cell quiescence precedes the onset of microbial flora-dependent wasting disease and intestinal inflammation in gimap5-deficient mice. The Journal of Immunology, 184(7):3743–3754, April 2010. URL: http://dx.doi.org/10.4049/jimmunol.0903164, doi:10.4049/jimmunol.0903164. This article has 56 citations.](https://doi.org/10.4049/jimmunol.0903164)